Drug price reforms: The new F1-F2 bifurcation

Thomas Faunce; Hans Lofgren

doi:10.18773/austprescr.2007.081

Drug price reforms: The new F1-F2 bifurcation

Thomas Faunce^*, Hans Lofgren

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

10 Citations (Scopus)

Original language	English
Pages (from-to)	138-140
Number of pages	3
Journal	Australian Prescriber
Volume	30
Issue number	6
DOIs	https://doi.org/10.18773/austprescr.2007.081
Publication status	Published - Dec 2007

Access to Document

10.18773/austprescr.2007.081

Cite this

@article{d0e49b10a76a428ba5d4ceb37fdb7188,

title = "Drug price reforms: The new F1-F2 bifurcation",

keywords = "Generic drugs, Pharmaceutical Benefits Scheme, Reference pricing",

author = "Thomas Faunce and Hans Lofgren",

year = "2007",

month = dec,

doi = "10.18773/austprescr.2007.081",

language = "English",

volume = "30",

pages = "138--140",

journal = "Australian Prescriber",

issn = "0312-8008",

publisher = "Therapeutic Guidelines Ltd",

number = "6",

}

TY - JOUR

T1 - Drug price reforms

T2 - The new F1-F2 bifurcation

AU - Faunce, Thomas

AU - Lofgren, Hans

PY - 2007/12

Y1 - 2007/12

KW - Generic drugs

KW - Pharmaceutical Benefits Scheme

KW - Reference pricing

UR - http://www.scopus.com/inward/record.url?scp=36849036730&partnerID=8YFLogxK

U2 - 10.18773/austprescr.2007.081

DO - 10.18773/austprescr.2007.081

M3 - Editorial

SN - 0312-8008

VL - 30

SP - 138

EP - 140

JO - Australian Prescriber

JF - Australian Prescriber

IS - 6

ER -

Drug price reforms: The new F1-F2 bifurcation

Access to Document

Other files and links

Cite this